Skip to content
  • Our Focus
  • Our Technology
  • Our Team
  • Newsroom
  • Investors
  • Contact Us
  • Our Focus
  • Our Technology
  • Our Team
  • Newsroom
  • Investors
  • Contact Us
  • Our Focus
  • Our Technology
  • Our Team
  • Newsroom
  • Investors
  • Contact Us
  • Our Focus
  • Our Technology
  • Our Team
  • Newsroom
  • Investors
  • Contact Us

News

Abstract for Presentation at the American Congress of Rheumatology (ACR) Congress 2019

By DA

Abstract for Presentation at the American Congress of Rheumatology (ACR) Congress 2019 Read More »

Pat Butler, Joins as Board Observer and Advisor.

By DA

Pat Butler, Joins as Board Observer and Advisor. Read More »

Serac Healthcare founded to develop a molecular imaging agent to help rheumatologists manage treatment decisions in their patients with rheumatoid arthritis

By DA

Serac Healthcare founded to develop a molecular imaging agent to help rheumatologists manage treatment decisions in their patients with rheumatoid arthritis Read More »

← Previous 1 … 3 4

Get in Touch

Reach out to us via email
info@seraclifesciences.com

Connect with Us

Follow us on social media
Follow us on LinkedIn
Serac Healthcare Limited Ltd is a wholly owned subsidiary of Serac Life Sciences Ltd.
Our Focus
  • Endometriosis
  • Inflammatory Arthritis
  • Pipeline
Our Technology
  • Molecular Imaging
  • 99mTc-maraciclatide
  • Publications
  • Our Team
  • Newsroom
  • Investors
  • Contact Us
Maraciclatide is for investigational use only and is not approved by the FDA or UK and European regulatory authorities.
Registered Office: 6th Floor, Charlotte Building, 17 Gresse Street, London W1T 1QL.
Company Number: 11074844. VAT No: 288 9284 31.

Copyright © 2024 by Serac Healthcare Ltd. | Privacy Policy

Powered by Serac Healthcare Ltd.